Envoy Medical (NASDAQ:COCH - Get Free Report) had its target price boosted by research analysts at Lake Street Capital from $3.00 to $6.00 in a note issued to investors on Wednesday, Benzinga reports. The brokerage presently has a "buy" rating on the stock. Lake Street Capital's price target would indicate a potential upside of 23.97% from the stock's current price.
https://www.marketbeat.com/instant-alerts/nasdaq-coch-boost-price-target-2024-04-03/
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.